Outlook Therapeutics (OTLK) Other Operating Expenses (2018 - 2026)
Outlook Therapeutics (OTLK) reported Other Operating Expenses of -$23.6 million for Q1 2026, down 209.29% year-over-year from $21.6 million in Q1 2025, and down 209.29% quarter-over-quarter from $21.6 million in Q1 2025.
Outlook Therapeutics (OTLK) Other Operating Expenses (2018 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has 8 years of Other Operating Expenses data on file, last reported at -$23.6 million in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at -$23.6 million, down 209.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$23.6 million (up 49.26% YoY), and the FY2025 annual result was -$70.2 million, down 3.18% from the prior year.
- Other Operating Expenses eased to -$23.6 million in Q1 2026 per OTLK's latest filing, from $21.6 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $21.6 million in Q1 2025 and troughed at -$68.0 million in Q3 2024.
- A 4-year average of -$14.2 million and a median of -$376963.0 in 2022 frame the typical range for Other Operating Expenses.
- On a YoY basis, Other Operating Expenses climbed as much as 209.29% in 2026 and fell as far as 209.29% in 2026.
- A 4-year view of Other Operating Expenses shows it stood at -$376963.0 in 2022, then sank by 17950.19% to -$68.0 million in 2024, then jumped by 131.71% to $21.6 million in 2025, then sank by 209.29% to -$23.6 million in 2026.
- Business Quant data shows OTLK's Other Operating Expenses at -$23.6 million in Q1 2026, $21.6 million in Q1 2025, and -$68.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.58 Mn |
| Mar 31, 2025 | 21.57 Mn |
| Sep 30, 2024 | -68.04 Mn |
| Jun 30, 2022 | -376,963.00 |
| Mar 31, 2022 | -343,585.00 |
| Dec 31, 2021 | -162,355.00 |
| Jun 30, 2020 | 104,296.00 |
| Mar 31, 2020 | 423,328.00 |
| Sep 30, 2019 | 8.31 Mn |
| Jun 30, 2019 | 50,927.00 |
| Mar 31, 2019 | 561,735.00 |
| Dec 31, 2018 | 2.35 Mn |